Y. Perrie

A. Mohammed, Y. Perrie, F. Alhusban, 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Investigating the role of cholesterol in the formation of non-ionic surfactant based bilayer vesicles: thermal analysis and molecular dynamics.

David E. Anderson, Y. Perrie, Jitinder S. Wilkhu, 2014, International journal of pharmaceutics.

Applying Microfluidics for the Production of the Cationic Liposome-Based Vaccine Adjuvant CAF09b

Y. Perrie, D. Christensen, S. Schmidt, 2020, Pharmaceutics.

Liposomal vaccine delivery systems

Y. Perrie, D. Christensen, K. Korsholm, 2011, Expert opinion on drug delivery.

Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response.

Yvonne Perrie, Dennis Christensen, Vincent W Bramwell, 2010, Journal of controlled release : official journal of the Controlled Release Society.

Rational design of adjuvants for subunit vaccines: The format of cationic adjuvants affects the induction of antigen-specific antibody responses.

C. Roberts, I. Ferlenghi, D. Veggi, 2020, Journal of controlled release : official journal of the Controlled Release Society.

Design of a novel vaccine nanotechnology-based delivery system comprising CpGODN-protein conjugate anchored to liposomes.

C. Roberts, U. D'Oro, R. Adamo, 2020, Journal of controlled release : official journal of the Controlled Release Society.

A novel microfluidic-based approach to formulate size-tuneable large unilamellar cationic liposomes: formulation, cellular uptake and biodistribution investigations.

C. Roberts, Giulia Anderluzzi, Gustavo Lou, 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Th1 immune responses can be modulated by varying dimethyldioctadecylammonium and distearoyl‐sn‐glycero‐3‐phosphocholine content in liposomal adjuvants

Y. Perrie, Alexander J. K. Wilkinson, Vincent W. Bramwell, 2013, The Journal of pharmacy and pharmacology.

A case-study investigating the physicochemical characteristics that dictate the function of a liposomal adjuvant

Y. Perrie, Alexander J. K. Wilkinson, E. Kastner, 2013, Human vaccines & immunotherapeutics.

Manipulation of the surface pegylation in combination with reduced vesicle size of cationic liposomal adjuvants modifies their clearance kinetics from the injection site, and the rate and type of T cell response.

Y. Perrie, Daniel J Kirby, R. Kaur, 2012, Journal of controlled release : official journal of the Controlled Release Society.

The application of monolayer studies in the understanding of liposomal formulations.

A. Mohammed, Y. Perrie, Daniel J Kirby, 2011, International journal of pharmaceutics.

Subunit vaccines: distearoylphosphatidylcholine-based liposomes entrapping antigen offer a neutral alternative to dimethyldioctadecylammonium-based cationic liposomes as an adjuvant delivery system.

Y. Perrie, S. McNeil, E. Agger, 2011, Journal of pharmaceutical sciences.

Increased potential of a cationic liposome-based delivery system: enhancing stability and sustained immunological activity in pre-clinical development.

A. Mohammed, Y. Perrie, Daniel J Kirby, 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Radiolabelling of Antigen and Liposomes for Vaccine Biodistribution Studies

Y. Perrie, Vincent W. Bramwell, M. Henriksen‐Lacey, 2010, Pharmaceutics.

Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses.

P. Andersen, Y. Perrie, Daniel J Kirby, 2005, Biochimica et biophysica acta.

A comparative study of cationic liposome and niosome‐based adjuvant systems for protein subunit vaccines: characterisation, environmental scanning electron microscopy and immunisation studies in mice

Y. Perrie, Daniel J Kirby, A. Vangala, 2006, The Journal of pharmacy and pharmacology.

Lyophilisation and sterilisation of liposomal vaccines to produce stable and sterile products.

A. Mohammed, Y. Perrie, Vincent W. Bramwell, 2006, Methods.

Liposome-based cationic adjuvant formulations (CAF): Past, present, and future

Y. Perrie, Daniel J Kirby, E. Agger, 2009, Journal of liposome research.

Liposomes in adjuvant systems for parenteral delivery of vaccines

A. Mohammed, Y. Perrie, Vincent W. Bramwell, 2009 .

The role of lipid geometry in designing liposomes for the solubilisation of poorly water soluble drugs.

A. Mohammed, Y. Perrie, Daniel J Kirby, 2013, International journal of pharmaceutics.

Translating the fabrication of protein-loaded poly(lactic-co-glycolic acid) nanoparticles from bench to scale-independent production using microfluidics

Y. Perrie, Carla B. Roces, D. Christensen, 2020, Drug Delivery and Translational Research.

Human rhinovirus-induced inflammatory responses are inhibited by phosphatidylserine containing liposomes

R. Hume, J. Harwood, C. Marshall, 2016, Mucosal Immunology.

Designing Liposomes as Vaccine Adjuvants

Y. Perrie, M. Henriksen-Lacey, Malou Henriksen-Lacey, 2013 .

Immunomic Discovery of Adjuvants and Candidate Subunit Vaccines

D. Flower, Y. Perrie, 2013, Immunomics Reviews:.

Preparation of Zein-Based Nanoparticles: Nanoprecipitation versus Microfluidic-Assisted Manufacture, Effects of PEGylation on Nanoparticle Characteristics and Cellular Uptake by Melanoma Cells

C. Dufès, Y. Perrie, Sukrut Somani, 2022, International journal of nanomedicine.

Rapid Quantification and Validation of Lipid Concentrations within Liposomes

Y. Perrie, Carla B. Roces, E. Kastner, 2016, Pharmaceutics.

Rapid Quantification and Validation of Lipid

Y. Perrie, Carla B. Roces, E. Kastner, 2016 .

Formulation and characterisation of PLGA microspheres as vaccine adjuvants

Y. Perrie, Daniel J Kirby, R. Kaur, 2013 .

PLGA microspheres for the delivery of a novel subunit TB vaccine

Y. Perrie, Daniel J Kirby, E. Agger, 2008, Journal of drug targeting.

Current Status and Future Perspectives on MRNA Drug Manufacturing

Y. Perrie, E. Ramsay, R. Broadhead, 2022, Molecular pharmaceutics.

Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: The impact of cationic lipid selection.

C. Roberts, I. Ferlenghi, Giulia Anderluzzi, 2020, Journal of controlled release : official journal of the Controlled Release Society.

Manufacturing Considerations for the Development of Lipid Nanoparticles Using Microfluidics

Gustavo Lou, Y. Perrie, Carla B. Roces, 2020, Pharmaceutics.

Synthesis of protein conjugates adsorbed on cationic liposomes surface

C. Roberts, R. Adamo, Y. Perrie, 2020, MethodsX.

PLGA microspheres for the delivery of a novel subunit TB vaccine.

Y. Perrie, Daniel J Kirby, E. Agger, 2008, Journal of drug targeting.

Investigation into the Use of Microfluidics in the Manufacture of Metallic Gold-Coated Iron Oxide Hybrid Nanoparticles

H. H. Yiu, Y. Perrie, C. Hoskins, 2021, Nanomaterials.

Particulate delivery systems for vaccines: what can we expect?

Y. Perrie, Vincent W. Bramwell, 2006, The Journal of pharmacy and pharmacology.

Cationic Adjuvant Formulation 01 (CAF01) but does not enhance immunopotentiation

Y. Perrie, Alexander J. K. Wilkinson, Carla B. Roces, 2018 .

Formulation design considerations for oral vaccines.

Y. Perrie, Daniel J Kirby, Jitinder S. Wilkhu, 2011, Therapeutic delivery.

Effects of ball-milling on PLGA polymer and its implication on lansoprazole-loaded nanoparticles

A. Mohammed, Y. Perrie, F. Alhusban, 2011, Journal of basic and clinical pharmacy.

Liposome-entrapped plasmid DNA: characterisation studies.

G. Gregoriadis, Y. Perrie, 2000, Biochimica et biophysica acta.

High potency of lipid conjugated TLR7 agonist requires nanoparticulate or liposomal formulation

K. Shankland, F. Greco, I. Hamley, 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Three-dimensional fluid pressure mapping in porous media using magnetic resonance imaging with gas-filled liposomes.

R. Morris, Y. Perrie, A. Vangala, 2007, Magnetic resonance imaging.

Title : Microfluidics based manufacture of liposomes simultaneously entrapping hydrophilic 1 and lipophilic drugs. 2

Giulia Anderluzzi, Y. Perrie, Maryam T. Hussain, 2018 .

and purification of tailored liposomes for drug delivery using a module-based micro continuous-flow system.

N. Dimov, Y. Perrie, Maryam T. Hussain, 2018 .

Preparation and Characterization of Gas-filled Liposomes: Can They Improve Oil Recovery?

R. Morris, Y. Perrie, A. Vangala, 2007, Journal of liposome research.

Environmental scanning electron microscope imaging of vesicle systems.

Y. Perrie, Daniel J Kirby, A. Vangala, 2010, Methods in molecular biology.

Environmental Scanning Electron Microscopy Offers Real-Time Morphological Analysis of Liposomes and Niosomes

Y. Perrie, A. Vangala, S. McNeil, 2007, Journal of liposome research.

Hussain, Mohammed Jubair and Wilkinson, Alexander and Bramwell, Vincent W. and Christensen, Dennis and Perrie, Yvonne (2014) Th1 immune responses can be modulated by varying dimethyldioctadecylammonium and distearoyl-sn-glycero-3-

Y. Perrie, Alexander J. K. Wilkinson, Vincent W. Bramwell, 2018 .

Effect of incorporating cholesterol into DDA:TDB liposomal adjuvants on bilayer properties, biodistribution, and immune responses.

A. Devitt, Y. Perrie, Jitinder S. Wilkhu, 2014, Molecular pharmaceutics.

Small Cationic DDA:TDB Liposomes as Protein Vaccine Adjuvants Obviate the Need for TLR Agonists in Inducing Cellular and Humoral Responses

A. Hill, C. Tang, Y. Perrie, 2012, PloS one.

Development of a rapid in vitro pre-screen for distinguishing effective liposome-adjuvant delivery systems

A. Devitt, Y. Perrie, E. Kastner, 2022, Scientific Reports.

Comparison of the depot effect and immunogenicity of liposomes based on dimethyldioctadecylammonium (DDA), 3β-[N-(N',N'-Dimethylaminoethane)carbomyl] cholesterol (DC-Chol), and 1,2-Dioleoyl-3-trimethylammonium propane (DOTAP): prolonged liposome retention mediates stronger Th1 responses.

Y. Perrie, Vincent W. Bramwell, E. Agger, 2011, Molecular pharmaceutics.

Mixing and Flow-Induced Silk Fibroin Self-Assembly in Microfluidic and Semi-Batch Nanoprecipitation

Y. Perrie, R. Rezwan, Matthew Sal, 2021 .

High‐throughput screening of excipients with a biological effect: a kinetic study on the effects of surfactants on efflux‐mediated transport

A. Mohammed, R. Badhan, Y. Perrie, 2019, The Journal of pharmacy and pharmacology.

Comparative Analysis of Protein Quantification Methods for the Rapid Determination of Protein Loading in Liposomal Formulations

Y. Perrie, Maryam T. Hussain, N. Forbes, 2019, Pharmaceutics.

Wilkhu, Jitinder S and McNeil, Sarah E and Anderson, David E and Perrie, Yvonne (2014) Consideration of the efficacy of non-ionic vesicles

Y. Perrie, Jitinder S. Wilkhu, S. McNeil, 2018 .

Consideration of the efficacy of non-ionic vesicles in the targeted delivery of oral vaccines

Y. Perrie, Jitinder S. Wilkhu, S. McNeil, 2014, Drug Delivery and Translational Research.

Wilkhu, Jitinder S. and McNeil, Sarah E. and Anderson, David E. and Kirchmeier, Marc and Perrie, Yvonne (2017) Development of a solid dosage platform for the oral delivery of bilayer

Y. Perrie, S. McNeil, M. Kirchmeier, 2018 .

Development of a solid dosage platform for the oral delivery of bilayer vesicles

Y. Perrie, Jitinder S. Wilkhu, S. McNeil, 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Entrapment of plasmid DNA vaccines into liposomes by dehydration/rehydration.

M. Obrenovich, G. Gregoriadis, B. McCormack, 2000, Methods in molecular medicine.

The effect of cationic lipid content on the physicochemical characteristics of liposome-entrapped DNA

G. Gregoriadis, Y. Perrie, 1999 .

Genetic immunization using liposome‐incorporated DNA

G. Gregoriadis, Y. Perrie, 1998 .

Gregory Gregoriadis: Introducing liposomes to drug delivery

Y. Perrie, 2008, Journal of drug targeting.

Indwelling catheters and medical implants with FXIIIa inhibitors: A novel approach to the treatment of catheter and medical device-related infections.

Y. Perrie, D. Lowry, P. Lambert, 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Investigating Prime-Pull Vaccination through a Combination of Parenteral Vaccination and Intranasal Boosting

Y. Perrie, Maryam T. Hussain, Carla B. Roces, 2019, Vaccines.

Silk Nanoparticle Manufacture in Semi-Batch Format.

Y. Perrie, Saphia A. L. Matthew, F. P. Seib, 2020, ACS biomaterials science & engineering.

Enhancing vaccine design strategies: applications for protein science, proteomics and adjuvants

David S. Jones, H. Griffiths, Y. Perrie, 2015, The Journal of pharmacy and pharmacology.

CHAPTER 2.4 – DNA vaccination: A role for liposomes

G. Gregoriadis, B. McCormack, Y. Perrie, 1998 .

Assessment of different formulations of oral Mycobacterium bovis Bacille Calmette-Guérin (BCG) vaccine in rodent models for immunogenicity and protection against aerosol challenge with M. bovis.

R. G. Hewinson, M. Chambers, Y. Perrie, 2008, Vaccine.

A holistic multi evidence approach to study the fragmentation behaviour of crystalline mannitol Journal Item

A. Mohammed, J. Bowen, Y. Perrie, 2018 .

Particle Size Analysis of Micro and Nanoparticles

Y. Perrie, E. Kastner, 2016 .

Lipoplexes formulation and optimisation: in vitro transfection studies reveal no correlation with in vivo vaccination studies.

Y. Perrie, A. Vangala, S. McNeil, 2010, Current drug delivery.

High-strength resorbable brushite bone cement with controlled drug-releasing capabilities.

J. Barralet, Y. Perrie, U. Gbureck, 2008, Acta biomaterialia.

Exposure of the Basophilic Cell Line KU812 to Liposomes Reveals Activation Profiles Associated with Potential Anaphylactic Responses Linked to Physico-Chemical Characteristics

Christopher A. W. David, Y. Perrie, C. David, 2022, Pharmaceutics.

Amino acids as cryoprotectants for liposomal delivery systems.

A. Mohammed, Y. Perrie, A. Coombes, 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Particulate delivery systems for vaccines.

Y. Perrie, Vincent W. Bramwell, 2005, Critical reviews in therapeutic drug carrier systems.

Investigation of Formulation and Process of Lyophilised Orally Disintegrating Tablet (ODT) Using Novel Amino Acid Combination

Alan M. Smith, L. Grover, A. Elshaer, 2010, Pharmaceutics.

Exploitation of the bilosome platform technology to formulate antibiotics and enhance efficacy of melioidosis treatments

C. Roberts, Y. Perrie, Stuart Woods, 2019, Journal of controlled release : official journal of the Controlled Release Society.

Immunomic Discovery of Adjuvants, Delivery Systems, and Candidate Subunit Vaccines: A Brief Introduction

D. Flower, Y. Perrie, 2012, Immunomic Discovery of Adjuvants and Candidate Subunit Vaccines.

Vaccine entrapment in liposomes.

G Gregoriadis, G. Gregoriadis, B. McCormack, 1999, Methods.

Delivery of the antibiotic gentamicin sulphate from precipitation cast matrices of polycaprolactone.

A. Coombes, Y. Perrie, H-I Chang, 2006, Journal of controlled release : official journal of the Controlled Release Society.

Analytical Techniques in the Pharmaceutical Sciences

T. Rades, A. Müllertz, Y. Perrie, 2016, Advances in Delivery Science and Technology.

Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.

Yvonne Perrie, Wim Jiskoot, W. Jiskoot, 2010, Journal of controlled release : official journal of the Controlled Release Society.

Adjuvant properties of a simplified C32 monomycolyl glycerol analogue.

Yvonne Perrie, Gurdyal S Besra, Vincent W Bramwell, 2009, Bioorganic & medicinal chemistry letters.

Liposomes: Advancements and innovation in the manufacturing process.

Yvonne Perrie, René Holm, Vivek Dhawan, 2020, Advanced drug delivery reviews.

Volumetric Scalability of Microfluidic and Semi-Batch Silk Nanoprecipitation Methods

Y. Perrie, Saphia A. L. Matthew, F. P. Seib, 2022, Molecules.

Effects of fibre reinforcement on the mechanical properties of brushite cement.

L. Grover, J. Barralet, Y. Perrie, 2006, Acta biomaterialia.

Solubilisation of drugs within liposomal bilayers: alternatives to cholesterol as a membrane stabilising agent

Yvonne Perrie, A. Mohammed, Y. Perrie, 2010, The Journal of pharmacy and pharmacology.

Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability.

A. Mohammed, Y. Perrie, N. Weston, 2004, International journal of pharmaceutics.

Scalable solvent‐free production of liposomes

Y. Perrie, Carla B. Roces, Swapnil Khadke, 2020, The Journal of pharmacy and pharmacology.

Microporous polycaprolactone matrices for drug delivery and tissue engineering: the release behaviour of bioactives having extremes of aqueous solubility

A. Coombes, Y. Perrie, Hsin-I Chang, 2010 .

Polycaprolactone fibres as a potential delivery system for collagen to support bone regeneration.

H. Griffiths, Y. Perrie, S. McNeil, 2011, Current drug delivery.

A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analog.

Yvonne Perrie, Dennis Christensen, J. Christensen, 2012, Journal of controlled release : official journal of the Controlled Release Society.

Using microfluidics for scalable manufacturing of nanomedicines from bench to GMP: A case study using protein-loaded liposomes.

Yvonne Perrie, Jonathan W. Aylott, J. Aylott, 2020, International journal of pharmaceutics.

Pharmaceutics: A New Open-Access Journal for All Those Interested in Designing Medicines

A. Mohammed, Y. Perrie, 2009, Pharmaceutics.

Preparation, characterisation and entrapment of a non-glycosidic threitol ceramide into liposomes for presentation to invariant natural killer T cells.

G. Besra, V. Cerundolo, Y. Perrie, 2011, Journal of pharmaceutical sciences.

Comparison of vesicle based antigen delivery systems for delivery of hepatitis B surface antigen.

Yvonne Perrie, Dennis Christensen, Vincent W Bramwell, 2007, Journal of controlled release : official journal of the Controlled Release Society.

Microfluidic Manufacture of Solid Lipid Nanoparticles: A Case Study on Tristearin-Based Systems

Giulia Anderluzzi, Y. Perrie, 2020, Drug Delivery Letters.

Scalable Manufacturing Processes for Solid Lipid Nanoparticles.

Giulia Anderluzzi, Gustavo Lou, Y. Perrie, 2019, Pharmaceutical nanotechnology.

Does dysregulation of redox state underpin the decline of innate immunity with ageing?

H. Griffiths, Y. Perrie, M. C. Rooney, 2020, Antioxidants & redox signaling.

Characterization of Microvesicles Released from Human Red Blood Cells

D. Nguyen, A. Devitt, I. Bernhardt, 2016, Cellular Physiology and Biochemistry.

Subunit Vaccine Delivery

T. Rades, C. Foged, Y. Perrie, 2015, Advances in Delivery Science and Technology.

Genomic evaluation during permeability of indomethacin and its solid dispersion

A. Elshaer, Ayesha Rahman, A. Mohammed, 2011, Journal of drug targeting.

Liposomes: a promising carrier for respiratory syncytial virus therapeutics

Y. Perrie, Sameer Joshi, S. Singh, 2019, Expert opinion on drug delivery.

Activated carbon as a carrier for amorphous drug delivery: Effect of drug characteristics and carrier wettability

Y. Perrie, D. Lowry, D. Ouyang, 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

The rational design of vaccines

Y. Perrie, Vincent W. Bramwell, 2005, Drug Discovery Today.

Conceptualisation, Development, Fabrication and In Vivo Validation of a Novel Disintegration Tester for Orally Disintegrating Tablets

A. Mohammed, Y. Perrie, A. Rajabi-Siahboomi, 2019, Scientific Reports.

Precipitation casting of drug-loaded microporous PCL matrices: incorporation of progesterone by co-dissolution.

A. Coombes, Y. Perrie, M. Williamson, 2005, Journal of controlled release : official journal of the Controlled Release Society.

Formulation of multiparticulate systems as lyophilised orally disintegrating tablets.

A. Mohammed, Y. Perrie, F. Alhusban, 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Preparation, optimisation and characterisation of lyophilised rapid disintegrating tablets based on gelatin and saccharide.

A. Mohammed, Y. Perrie, F. Alhusban, 2010, Current drug delivery.

Freeze-drying cycle optimization for the rapid preservation of protein- loaded liposomal formulations.

Y. Perrie, Maryam T. Hussain, N. Forbes, 2019, International journal of pharmaceutics.

Al-Khattawi, Ali and Koner, Jasdip and Rue, Peter and Kirby, Dan and Perrie, Yvonne and Rajabi-Siahboomi, Ali and Mohammed, Afzal R. (2015) A pragmatic approach for engineering porous mannitol and mechanistic evaluation

A. Mohammed, Y. Perrie, A. Rajabi-Siahboomi, 2017 .

A pragmatic approach for engineering porous mannitol and mechanistic evaluation of particle performance.

A. Mohammed, Y. Perrie, A. Rajabi-Siahboomi, 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Polymer film formulations for the preparation of enteric pharmaceutical capsules

Alan M. Smith, L. Grover, Y. Perrie, 2010, The Journal of pharmacy and pharmacology.

Rapid and scale-independent microfluidic manufacture of liposomes entrapping protein incorporating in-line purification and at-line size monitoring.

Yvonne Perrie, Nicolas Szita, J. H. T. Horst, 2019, International journal of pharmaceutics.

Systems biology approach to study permeability of paracetamol and its solid dispersion.

A. Elshaer, Ayesha Rahman, A. Mohammed, 2011, International journal of pharmaceutics.

1 Title : Investigating the role of cholesterol in the formation of non-ionic surfactant based bilayer vesicles : thermal analysis and molecular dynamics

Y. Perrie, Jitinder S. Wilkhu, D. Ouyang, 2017 .

The Application of Liposomes as Vaccine Adjuvants

Y. Perrie, Alexander J. K. Wilkinson, E. Kastner, 2015 .

Designing liposomal adjuvants for the next generation of vaccines.

Yvonne Perrie, Helen R Griffiths, Andrew Devitt, 2016, Advanced drug delivery reviews.

The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8+ T-cell responses: The immunological consequences of the biodistribution profile

Thomas Rades, Yvonne Perrie, Dennis Christensen, 2016, Journal of controlled release : official journal of the Controlled Release Society.

Influenza: treatment and prevention

Y. Perrie, 2006 .

Characterization and optimization of bilosomes for oral vaccine delivery

Y. Perrie, Jitinder S. Wilkhu, S. McNeil, 2013, Journal of drug targeting.

The Impact of Solvent Selection: Strategies to Guide the Manufacturing of Liposomes Using Microfluidics

Y. Perrie, Carla B. Roces, Swapnil Khadke, 2019, Pharmaceutics.

Non-canonical inflammasome activation mediates the adjuvanticity of nanoparticles

A. Bowie, Giulia Anderluzzi, Y. Perrie, 2023, Cell reports. Medicine.

Lipid conjugation of TLR7 agonist Resiquimod ensures co‐delivery with the liposomal Cationic Adjuvant Formulation 01 (CAF01) but does not enhance immunopotentiation compared to non‐conjugated Resiquimod+CAF01

Yvonne Perrie, Dennis Christensen, Y. Perrie, 2018, Journal of controlled release : official journal of the Controlled Release Society.

Lipid conjugation of TLR 7 agonist Resiquimod ensures co-delivery with the liposomal Cationic Adjuvant Formulation 01 ( CAF 01 ) but does not enhance immunopotentiation compared to non-conjugated Resiquimod + CAF 01

Carla, Y. Perrie, Eric, 2018 .

Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen.

Yvonne Perrie, Dennis Christensen, Vincent W Bramwell, 2010, Journal of controlled release : official journal of the Controlled Release Society.

Rapid scale-up and production of active-loaded PEGylated liposomes.

J. Aylott, Y. Perrie, Carla B. Roces, 2020, International journal of pharmaceutics.

Microfluidic-controlled manufacture of liposomes for the solubilisation of a poorly water soluble drug.

Yvonne Perrie, Elisabeth Kastner, Y. Perrie, 2015, International journal of pharmaceutics.

Scale-independent microfluidic production of cationic liposomal adjuvants and development of enhanced lymphatic targeting strategies.

Yvonne Perrie, Dennis Christensen, Y. Perrie, 2019, Molecular pharmaceutics.

Formulation and manufacturing of lymphatic targeting liposomes using microfluidics.

Yvonne Perrie, Andrew Devitt, A. Devitt, 2019, Journal of controlled release : official journal of the Controlled Release Society.

Microfluidic production of protein loaded chimeric stealth liposomes.

L. Casettari, Y. Perrie, Mattia Tiboni, 2020, International journal of pharmaceutics.

Microscopy imaging of liposomes: from coverslips to environmental SEM.

Yvonne Perrie, Dennis Christensen, Afzal R Mohammed, 2011, International journal of pharmaceutics.

Physicochemical characterisation, drug polymer dissolution and in vitro evaluation of phenacetin and phenylbutazone solid dispersions with polyethylene glycol 8000.

Hannah Batchelor, Yvonne Perrie, Sheraz Khan, 2011, Journal of pharmaceutical sciences.

Formation and purification of tailored liposomes for drug delivery using a module-based micro continuous-flow system

N. Szita, N. Dimov, Y. Perrie, 2017, Scientific Reports.

Liposomes, lipid assemblies, nanotechnology, and everything interesting in between

Y. Perrie, 2009 .

Vaccines

Y. Perrie, R. Kaur, Malou Henriksen-Lacey, 2013, Reactions Weekly.

Wilkhu, Jitinder S. and McNeil, Sarah E. and Anderson, David E. and Perrie, Yvonne (2013) Characterization and optimization of bilosomes

Y. Perrie, S. McNeil, D. Anderson, 2018 .

The Effect of Bilosomes and Vesicle Size on the Oral Biodistr ibution of a H 3 N 2 Subunit Antigen

Y. Perrie, Jitinder S. Wilkhu, D. Anderson, 2013 .

Metallosomes for biomedical applications by mixing molybdenum carbonyl metallosurfactants and phospholipids.

Y. Perrie, N. Benseny-Cases, R. Barnadas-Rodríguez, 2018, Dalton transactions.

Evaluation of anti-biofilm activity of acidic amino acids and synergy with ciprofloxacin on Staphylococcus aureus biofilms

Ayesha Rahman, A. Mohammed, Y. Perrie, 2020, Scientific Reports.

Liposomes act as stronger sub-unit vaccine adjuvants when compared to microspheres

Y. Perrie, E. Agger, P. Andersen, 2008, Journal of drug targeting.

Microfluidics based manufacture of liposomes simultaneously entrapping hydrophilic and lipophilic drugs.

Giulia Anderluzzi, Y. Perrie, Maryam T. Hussain, 2016, International journal of pharmaceutics.

3D culture of bone-derived cells immobilised in alginate following light-triggered gelation.

Alan M. Smith, R. Shelton, Y. Perrie, 2007, Journal of controlled release : official journal of the Controlled Release Society.

Pegylation of DDA:TDB liposomal adjuvants reduces the vaccine depot effect and alters the Th1/Th2 immune responses.

Yvonne Perrie, Vincent W Bramwell, Y. Perrie, 2012, Journal of controlled release : official journal of the Controlled Release Society.

Manufacturing Methods for Liposome Adjuvants.

Y. Perrie, Carla B. Roces, E. Kastner, 2016, Methods in molecular biology.

Correlating liposomal adjuvant characteristics to in‐vivo cell‐mediated immunity using a novel Mycobacterium tuberculosis fusion protein: a multivariate analysis study

Y. Perrie, E. Kastner, Vincent W. Bramwell, 2015, The Journal of pharmacy and pharmacology.

Kastner, Elisabeth and Hussain, M. Jubair and Bramwell, Vincent W. and Christensen, Dennis and Perrie, Yvonne (2015) Correlating liposomal adjuvant characteristics to in-vivo cell-mediated immunity using a novel Mycobacterium tuberculosis fusion protein : a multivariate analysis

Y. Perrie, Vincent W. Bramwell, M. Hussain, 2018 .

Formation and purification of tailored liposomes for 1 drug delivery using a module-based micro continuous-2 flow system 3 4

N. Dimov, Y. Perrie, Maryam T. Hussain, 2017 .

Trigger release liposome systems: local and remote controlled delivery?

A. Mohammed, Y. Perrie, S. Bibi, 2012, Journal of microencapsulation.

The vesicle size of DDA:TDB liposomal adjuvants plays a role in the cell-mediated immune response but has no significant effect on antibody production.

Yvonne Perrie, Andrew Devitt, A. Devitt, 2011, Journal of controlled release : official journal of the Controlled Release Society.

Anti-RSV Peptide-Loaded Liposomes for the Inhibition of Respiratory Syncytial Virus †

Y. Perrie, Sameer Joshi, S. Singh, 2018, Bioengineering.

1 Title : Using microfluidics for scalable manufacturing of nanomedicines from bench to GMP : 1 A case study using protein-loaded liposomes

Giulia Anderluzzi, Gustavo Lou, Y. Perrie, 2020 .

Mixing and flow-induced nanoprecipitation for morphology control of silk fibroin self-assembly

Y. Perrie, Saphia A. L. Matthew, F. P. Seib, 2022, RSC advances.

Nanomedicines for the Delivery of Biologics

R. Mrsny, F. Greco, A. Jones, 2019, Pharmaceutics.

Targeted delivery of a novel group of site-directed transglutaminase inhibitors to the liver using liposomes: a new approach for the potential treatment of liver fibrosis

Y. Perrie, R. Collighan, M. Griffin, 2011, Journal of drug targeting.

Entrapment of plasmid DNA into niosomes: Characterization studies

G. Gregoriadis, Y. Perrie, Milka Mia Obrenovic, 1998 .

Alginate Beads as Potential Oral Vaccine Delivery Platforms: Effect of Coating

Alan M. Smith, Y. Perrie, H. Batchelor, 2007 .

Themed issue: Improve dissolution, solubility and bioavailability of poorly soluble drugs

T. Rades, Y. Perrie, 2010, The Journal of pharmacy and pharmacology.

Targeting circulating monocytes with CCL2-loaded liposomes armed with an oncolytic adenovirus.

C. Lewis, M. Essand, Y. Perrie, 2021, Nanomedicine : nanotechnology, biology, and medicine.

Chain length impact on the retro Diels-Alder mediated release of gemcitabine from hybrid nanoparticles towards pancreatic cancer therapy.

Y. Perrie, A. Curtis, C. Hoskins, 2023, International journal of pharmaceutics.

Translating the fabrication of protein-loaded poly(lactic-co-glycolic acid) nanoparticles from bench to scale-independent production using microfluidics

Y. Perrie, Carla B. Roces, D. Christensen, 2020, Drug Delivery and Translational Research.

Non-canonical inflammasome activation mediates the adjuvanticity of nanoparticles

A. Bowie, Giulia Anderluzzi, Y. Perrie, 2023, Cell reports. Medicine.

Principles of controlled release

T. Rades, Y. Perrie, K. Graeser, 2016 .

Drug Delivery

A. D'emanuele, Y. Perrie, D. Attwood, 2007, An Introduction to Biomaterials Science and Engineering.

Solubilisation of drugs within liposomal bilayers: alternatives to cholesterol as a membrane stabilising agent

Y. Perrie, Daniel J. Kirby, M. H. Ali, 2010, The Journal of pharmacy and pharmacology.

Characterization and optimization of bilosomes for oral vaccine delivery

Y. Perrie, Jitinder S. Wilkhu, S. McNeil, 2013, Journal of drug targeting.

Investigating the Impact of Polymer Blends on Drug Release from Polymer Matrices

Y. Perrie, A. Rajabi-Siahboomi, John Pollard, 2013 .

The vesicle size of DDA:TDB liposomal adjuvants plays a role in the cell-mediated immune response but has no significant effect on antibody production.

A. Devitt, Y. Perrie, Malou Henriksen-Lacey, 2011, Journal of controlled release : official journal of the Controlled Release Society.

Enhancing vaccine design strategies: applications for protein science, proteomics and adjuvants

David S. Jones, Y. Perrie, H. Griffiths, 2015, The Journal of pharmacy and pharmacology.

Dissolution rate enhancement, in vitro evaluation and investigation of drug release kinetics of chloramphenicol and sulphamethoxazole solid dispersions

Y. Perrie, I. Saleem, H. Batchelor, 2013, Drug development and industrial pharmacy.

Genomic evaluation during permeability of indomethacin and its solid dispersion

A. Elshaer, Ayesha Rahman, Y. Perrie, 2011, Journal of drug targeting.

A Holistic Multi Evidence Approach to Study the Fragmentation Behaviour of Crystalline Mannitol

J. Bowen, Y. Perrie, A. Rajabi-Siahboomi, 2015, Scientific Reports.

Russell, Craig and Begum, Sumyra and Hussain, Yasar and Hussain, Majad and Huen, David and Rahman, Ayesha S. and Perrie, Yvonne and Mohammed, Afzal R. (2015) Paediatric drug development of ramipril

D. Huen, Ayesha Rahman, Y. Perrie, 2018 .